Early prediction of triple negative breast cancer response to cisplatin treatment using diffusion-weighted MRI and 18F-FDG-PET.

Huong Nguyen-ThuHirofumi HanaokaTakahito NakajimaAiko YamaguchiTien Nguyen-CongA Adhipatria P KartamihardjaYoshito Tsushima

Published in: Breast cancer (Tokyo, Japan) (2018)

The ratios of ADCmean, SUVmax, and MTV have the potential to predict the therapeutic response and to screen non-responders in the ultra-early phase following cisplatin treatment in patients with TNBC.

Keyphrases

diffusion weighted
contrast enhanced
magnetic resonance imaging
computed tomography
positron emission tomography
pet ct
pet imaging
magnetic resonance
combination therapy
high throughput
mass spectrometry
climate change
single cell